Antidiabetic preparation for oral administration

作者: Nobutaka Ninomiya , Chisato Makino , Haruo Orita , Hidetoshi Sakai , Shigeru Shioya

DOI:

关键词: NateglinideEndocrinologyInternal medicineNormal levelOral administrationMedicineAntidiabetic preparationFasting blood glucose levelControlled release drugDrugPost prandial blood glucose

摘要: There is provided a single preparation which directly decreases both of the post prandial blood glucose level and fasting close to normal levels, by release-sustaining drug capable decreasing diabetic patients level, or mixing controlled release with an immediate drug. It particularly preferable that nateglinide.

参考文章(25)
Malaisse Wj, Bakkali-Nadi A, Malaisse-Lagae F, Insulinotropic action of meglitinide analogs: concentration-response relationship and nutrient dependency. Diabetes research (Scotland). ,vol. 27, pp. 81- 87 ,(1994)
Masanao Ozaki, Akira Yabuki, Takahiko Ando, Nobutaka Ninomiya, Masato Kaida, Tablet composition of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine ,(2000)
Lisbeth Tofte Hemmingsen, Peter Giortz Müller, Novel niddm regimen ,(1998)
Anees Abdulquadar Karnachi, Christiane Guitard, Richard Owen Mannion, Marjorie Regan Gatlin, Michele Ann Ball, Malcolm Allison, Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes ,(2000)
Grant Wayne Heinicke, Angelo Mario Morella, Ian Hamilton Pitman, Taste masked liquid suspensions ,(1997)
Johannes Jan Platteeuw, Den Heuvel Dennie Johan Marijn Van, Dalen Frans Van, Jacques Maria Lemmens, Modified release formulations containing a hypnotic agent ,(2001)
William N. Washburn, Bruce Ellsworth, Philip M. Sher, Wei Meng, Gang Wu, C-aryl glucoside SGLT2 inhibitors and method ,(2003)